Please ensure Javascript is enabled for purposes of website accessibility

Why Invacare Stock Soared 15.9% Today

By Todd Campbell - Updated Feb 10, 2020 at 4:32PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors are optimistic a turnaround will pay off in 2020.

What happened

Despite reporting fourth-quarter financials that were shy of analysts' expectations on the top and bottom lines, optimism that a restructuring will produce better results in 2020 sent shares of Invacare (IVC -5.06%) 15.9% higher Monday.

So what

Net sales fell 4.8% year over year to $232.9 million in Q4 2019, largely because of a $3.3 million drop in sales of respiratory products. After accounting for costs and charges associated with its restructuring, its loss clocked in at an adjusted $0.28 per share. Industry watchers were expecting sales to be $8.4 million higher and adjusted EPS to be $0.15 better than what management reported.

A megaphone with letters shooting out of it.

Image source: Getty Images.

Although the healthcare company fell short of what investors were forecasting, cost-cutting and guidance for growth this year have sparked investor interest, particularly given the company's low valuation. Gross margin improved 1.3% year over year. And excluding restructuring charges, adjusted EPS would have improved $0.07 year over year last quarter. 

In 2020, management's calling for net sales growth between 2% and 4%, free cash flow of over $5 million, and adjusted EBITDA of $85 million to $105 million. The improving performance could mean the company's shares are undervalued at a price-to-book ratio of just 0.93.

Now what

Invacare's business performance is usually loaded toward the back half of the year because of the timing of employee bonuses and seasonal purchasing patterns. This has management expecting flattish growth this quarter, with improvement in the subsequent quarters.  

The restructuring so far has reduced selling, general, and administrative costs as a percentage of revenue, but management thinks there's additional leverage it can squeeze from the business. It stands to benefit from consolidating manufacturing and the implementation of a new IT system. As for sales, it expects tailwinds from new products across all of its product categories, including wheelchairs, beds, and portable oxygen, and investments in its sales team.

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Invacare Corporation Stock Quote
Invacare Corporation
IVC
$0.83 (-5.06%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
334%
 
S&P 500 Returns
117%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.